| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 31, 2023 | IDXX Idexx Laboratories Inc /de | Mazelsky Jonathan Jay63 | President And CEO | Sell | 13,424 | $512.01 | $6,873,266.54 | -15.5% | -8.7% | -5.9% | |
| Aug 31, 2023 | LFWD Lifeward Ltd. | Lynch Jeannine80 | VP Of Market Access &Strategy | Sell | 9,529 | $0.69 | $6,561.67 | -2.5% | -0.7% | -31.0% | |
| Aug 31, 2023 | EW Edwards Lifesciences Corp | Ullem Scott B.65 | Cvp, Chief Financial Officer | Sell | 7,255 | $77.79 | $564,366.45 | -27.4% | -11.8% | -8.5% | |
| Aug 31, 2023 | TMDX Transmedics Group, Inc. | Provost Miriam | VP, Global Regulatory Affairs | Sell | 2,708 | $66.52 | $180,136.16 | -10.3% | +11.0% | +156.1% | |
| Aug 31, 2023 | SONX Sonendo, Inc. | Chen Roy T | Chief Talent Officer | Sell | 1,700 | $1.01 | $1,712.58 | -0.5% | - | - | |
| Aug 31, 2023 | UFPT Ufp Technologies Inc | Bailly R Jeffrey55 | President And CEO | Sell | 16,501 | $176.45 | $2,911,657.06 | -3.8% | -2.2% | +94.2% | |
| Aug 31, 2023 | MODD Modular Medical, Inc. | Frank Morgan C. | Director, 10% Owner | Buy | 145,949 | $1.07 | $155,507.24 | +89.5% | +8.7% | +60.0% | |
| Aug 30, 2023 | BFLY Butterfly Network, Inc. | Devivo Joseph | President &CEO | Buy | 10,000 | $1.81 | $18,100.00 | +0.3% | -44.7% | -40.6% | |
| Aug 30, 2023 | SENS Senseonics Holdings, Inc. | Roeder Douglas A69 | Director | Buy | 300,000 | $0.54 | $162,000.00 | +59.1% | +9.7% | -27.5% | |
| Aug 30, 2023 | ZBH Zimmer Biomet Holdings, Inc. | Kolli Sreelakshmi | Director | Buy | 1,000 | $120.37 | $120,370.00 | New | -5.9% | -4.6% | |
| Aug 30, 2023 | STXS Stereotaxis, Inc. | Isaac Paul J78 | Director, See Remarks | Buy | 10,000 | $1.71 | $17,100.00 | +0.4% | -1.2% | +34.7% | |
| Aug 30, 2023 | MYO Myomo, Inc. | Gudonis Paul R67 | Chief Executive Officer | Buy | 48,400 | $0.74 | $36,038.64 | +5.8% | +331.1% | +478.4% | |
| Aug 30, 2023 | MXCT Maxcyte, Inc. | Johnston John Joseph75 | Director | Sell | 5,000 | $3.70 | $18,500.00 | -1.4% | +25.8% | +15.9% | |
| Aug 30, 2023 | INFU Infusystem Holdings, Inc | Malhotra R. Rimmy72 | Director | Sell | 20,000 | $10.29 | $205,769.00 | -6.8% | -1.7% | -36.3% | |
| Aug 29, 2023 | MYO Myomo, Inc. | Kovelman Harry68 | Chief Medical Officer | Buy | 8,333 | $0.60 | $4,999.80 | +5.9% | +325.1% | +410.2% | |
| Aug 29, 2023 | TMDX Transmedics Group, Inc. | Weill David63 | Director | Buy | 2,500 | $62.00 | $155,000.00 | +22.3% | +9.4% | +163.0% | |
| Aug 29, 2023 | RGEN Repligen Corp | Dawes Karen A63 | Director | Sell | 850 | $171.38 | $145,673.00 | -1.0% | -7.3% | -15.5% | |
| Aug 29, 2023 | LFWD Lifeward Ltd. | Turk Joseph E Jr | Director | Buy | 1,616 | $0.62 | $993.84 | New | +3.7% | -32.8% | |
| Aug 29, 2023 | IDXX Idexx Laboratories Inc /de | Polewaczyk James F66 | Executive Vice President | Sell | 22,909 | $510.56 | $11,696,446.18 | -15.0% | -6.2% | -5.9% | |
| Aug 29, 2023 | MYO Myomo, Inc. | Henry David A72 | Chief Financial Officer | Buy | 41,666 | $0.60 | $24,999.60 | +13.4% | +325.1% | +410.2% | |
| Aug 29, 2023 | RXST Rxsight, Inc. | Maniar Shweta62 | Director | Sell | 4,292 | $28.06 | $120,450.69 | -14.7% | +5.1% | +89.9% | |
| Aug 29, 2023 | EW Edwards Lifesciences Corp | Chopra Daveen59 | Cvp, Tmtt | Sell | 1,500 | $76.69 | $115,040.40 | -5.9% | -13.7% | -11.8% | |
| Aug 29, 2023 | BSX Boston Scientific Corp | Mirviss Jeffrey B.45 | EVP&Pres, Periph Intervent | Sell | 18,628 | $53.48 | $996,229.63 | -12.9% | +1.8% | +45.4% | |
| Aug 29, 2023 | IRMD Iradimed Corp | Susi Roger E.53 | CEO, President, Chairman | Sell | 10,000 | $47.32 | $473,187.65 | -1.5% | -15.0% | -1.6% | |
| Aug 29, 2023 | MYO Myomo, Inc. | Gudonis Paul R67 | Chief Executive Officer | Buy | 79,500 | $0.76 | $60,591.35 | +5.2% | +325.1% | +410.2% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.